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Abstract
In recent years, the mammary gland epithelium has been shown to
be a mixture of differentiated cell populations in a hierarchical
relationship with their stem and progenitor cells. However, the
mechanisms that regulate their cellular differentiation processes
are still unclear. The identification of genes that govern stem and
progenitor cell expansion, or that determine daughter cell fate, will
be of crucial interest for understanding breast cancer diversity and,
ultimately, improving treatment. Two recent analyses have
identified some of the key genes that regulate these processes,
lighting up the highway to normal mammary gland development.
In the mammary epithelium, recent successes in identifying
stem and progenitor cells and lineage-specific transcription
factors have raised the possibility of a much deeper under-
standing of what controls lineage commitment and cell fate.
We have some way to go before we can approach the current
level of understanding of haematopoietic lineage commitment.
Nevertheless, every new report adds another piece to the
puzzle and two recent publications have done just that.
Pietersen and co-workers have described the expression of
Bmi1 in mammary cells and its crucial role in mouse mammary
gland biology [1]. Bmi1 is a member of the polycomb group
of proteins and a regulator of stem/progenitor cell function in
other systems [2,3]. However, Pietersen and co-workers
found that Bmi1 was expressed in all mammary epithelial cells
and reported the profound inhibition of mammary gland
development in a Bmi1 knockout mouse model, as well as a
reduction of the mammary stem cell activity and premature
lobuloalveolar differentiation. Interestingly, the co-deletion of
Ink4a/Arf (repressors of the cell cycle down-regulated by
Bmi1) partially rescued normal mammary gland development,
whereas pregnancy did so completely. Thus, Bmi1 regulates
stem and progenitor cell proliferation not only through the
inhibition of Ink4a/Arf, but also through the inhibition of other
genes related to differentiation processes that are signifi-
cantly up-regulated by pregnancy.
While Bmi1 is a gene ubiquitously expressed in mammary
cells, other genes are differentially expressed between cell
populations and are important for lineage commitment and
cell-fate. Raouf and co-workers [4] have recently compared
the gene expression profiles of four human mammary cell
populations isolated using cell-surface marker expression.
Genes from the NOTCH signalling pathway, known to
regulate cell fate decisions in other systems [5-7], were
described as differentially expressed between two cell
populations with different colony forming capacities:
undifferentiated or bipotent colony forming cells (CFCs) and
luminal-restricted CFCs. NOTCH4 was highly expressed in
bipotent CFCs and markedly down-regulated in luminal-
restricted CFCs, whereas an opposite pattern was found for
NOTCH3 and HES6, as well as for NOTCH1 and NOTCH2
(although the changes were less dramatic for the latter two
genes). Functional studies in which NOTCH3 signalling was
blocked in bipotent CFCs showed a substantial decrease in
formation of luminal-type colonies and an increase in
myoepithelial-type colonies, leading the authors to propose
NOTCH3 as one of the key genes for the luminal cell
commitment. Although it was not directly demonstrated, it
seems likely that the bipotent CFCs correspond to stem
and/or multilineage progenitor cells whereas the luminal
CFCs correspond to a lineage-restricted progenitor population.
These studies have highlighted two classes of genes driving
mammary epithelial cell differentiation: genes accelerating or
putting brakes on the development and differentiation
processes (‘traffic lights’); and genes defining directions in
these processes (‘road signs’) (Figure 1). Bmi1 is a promoter
of stem and progenitor cell expansion but blocks differen-
tiation, preventing its premature initiation [1]. Interestingly,
both studies agreed in describing Bmi1 as commonly
expressed in all mammary cells [1,4]. In addition, pregnancy
favours both cell expansion and differentiation, co-operating
with Bmi1 in regulating stem cell kinetics but opposing its
Viewpoint
Highway to heaven: mammary gland development and
differentiation
Lorenzo Melchor and Matthew J Smalley
Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK
Corresponding author: Matthew J Smalley, matthew.smalley@icr.ac.uk
Published: 6 October 2008 Breast Cancer Research 2008, 10:305 (doi:10.1186/bcr2147)
This article is online at http://breast-cancer-research.com/content/10/5/305
© 2008 BioMed Central Ltd
CFC, colony forming cell.
Page 2 of 3
(page number not for citation purposes)
Breast Cancer Research    Vol 10 No 5 Melchor and Smalley
effects in differentiation [1]. On the other hand, the NOTCH
signalling pathway determines mammary cell fate, as in other
tissues [6,7]. In previous studies on human mammospheres,
NOTCH4 was shown to be essential for maintaining
stem/progenitor cell activity and to direct progenitor cells to
myoepithelial cell commitment [8], indicating a dual role for
NOTCH4 as a ‘traffic light’ gene in stem cells but a ‘road
sign’ gene in progenitor cells. Raouf and colleagues have
confirmed the importance of NOTCH signalling pathways in
mammary gland biology, showing that the luminal cell lineage
is defined by down-regulation of NOTCH4 and the increase
of NOTCH3. This NOTCH signalling role in cell-fate determi-
nation is also supported by conditional knockout mouse models
of Notch effectors [9]. Although an interaction between
Notch and Bmi1 has not been shown in these studies, a
complex interacting model may exist with the involvement of
Hedgehog and Wnt signalling pathways for the self-renewal
and differentiation in mammary stem cells, as previously
proposed [10].
Given that both traffic lights and road signs must be phased
correctly for smooth fate determination, it is important to be
able to integrate studies that address stem/progenitor cell
kinetics and lineage commitment in both human and rodent
systems. However, the different cell-sorting methods currently
in use to isolate mammary cell populations, and the differing
terminology used to describe them, confound our ability to
create coherent models. Once the cell markers we use have
been fully validated, the mammary stem cell community should
be encouraged to develop common isolation protocols and
nomenclature to facilitate the integration of data.
The mammary stem cell field has changed almost beyond
recognition in the last five years. We are now in a position to
go further than simply identifying stem cells and to truly begin
to understand the molecular control of cell fate in the stem-
progenitor-differentiated cell hierarchy. This is not simply an
academic exercise. We feel (as no doubt do many others
working in the field) that the different gene expression profiles
of different breast cancer subtypes reflect real underlying
differences in the cells of origin of these tumours and in the
differentiation potential of these cells [11-13]. Therefore, we
feel that molecular pathology data can only be fully
interpreted and understood by reference to normal mammary
epithelial cell subtypes and the regulation of their
differentiation. The more we understand lineage selection and
fate determination in the normal mammary epithelium, the
closer we get to a comprehensive understanding of the
biology of breast cancer subtypes.
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Figure 1
The highway code of mammary gland biology. A schematic representation of the processes involved are depicted in the top: stem cells (red) divide
symmetrically (giving rise to two stem cells) or asymmetrically (generating one stem cell and one progenitor cell) [11]. Progenitor cells proliferate
(green; progenitor cell expansion) before initiating their maturation to differentiated cells (blue; progenitor differentiation). These processes may be
accelerated (represented by green traffic lights), stopped (red traffic lights), or orientated through specific directions (direction arrows) under the
regulation of driver genes, either Bmi1, genes up-regulated by pregnancy, or the Notch signalling pathway.
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